EUVIMEDEUVIMED entdecken
ValidierungsstudieOpen Access · CC BY-NC 3.0

An Interpretable AdaBoost Model for 1-Year Readmission Risk Prediction in AECOPD Patients with Hypertension

Xinxin Zhang, Maolang He, Jingyi Zhang, Luna Zhao, Dong Liu iD

International Journal of Chronic Obstructive Pulmonary Disease · 2026

DOI: 10.2147/copd.s557298 ↗

Kurz gefasst

Validierungsstudie in der Zeitschrift International Journal of Chronic Obstructive Pulmonary Disease, 2026. Verfasst von Xinxin Zhang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pulmonary and Critical Care Medicine, The First Affiliated Hospital of Shihezi University, Shihezi, People's Republic of China. Hauptthemen laut MEDLINE: Patient Readmission, Pulmonary Disease, Chronic Obstructive, Hypertension, Decision Support Techniques. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Chronic obstructive pulmonary disease (COPD) complicated by hypertension imposes a substantial global health burden, with acute exacerbation of chronic obstructive pulmonary disease (AECOPD) significantly increasing 1-year readmission risk. This study aimed to develop and validate an interpretable machine learning (ML) model that predicts 1-year readmission risk in AECOPD patients complicated by hypertension using real-world data.

Methods

This retrospective cohort study enrolled 2042 patients with AECOPD complicated by hypertension from the First Affiliated Hospital of Shihezi University between 2015 and 2024. The data were split into training and test sets at a 7:3 ratio. Feature selection was performed based on machine learning methods. Eight ML models were trained and tested to construct predictive models. Model performance was evaluated by the area under the receiver operating characteristic curve (AUC), accuracy, recall, specificity, and F1-score. The Shapley additive explanation method (SHAP) was used to rank the feature importance and explain the final model. An online risk prediction tool was developed based on the optimal model to facilitate clinical application.

Results

The 1-year readmission rate of patients with AECOPD complicated by hypertension was 37.5%. Seven independent predictors, including times of inhospitalization, procalcitonin, total protein, international normalized ratio (INR), prothrombin time, D-dimer, and hypoproteinemia, were identified as the most valuable features for establishing the models. The AdaBoost model showed optimal performance, with an AUC of 0.884 in the test set and an average AUC of 0.889 in 5-fold cross-validation. SHAP analysis confirmed that times of inhospitalization were the strongest predictor, followed by INR and total protein. An online calculator was deployed (https://fast.statsape.com/tool/detail?id=17) for clinical use.

Conclusion

This study developed an interpretable AdaBoost-based online calculator for 1-year readmission risk assessment in AECOPD patients by hypertension. The tool highlight the importance of addressing hypercoagulability and nutritional status to reduce readmission risk. Further external multi-center validation is needed to enhance its generalizability.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Patient ReadmissionPulmonary Disease, Chronic ObstructiveHypertensionDecision Support TechniquesHumansRetrospective StudiesRisk AssessmentAgedRisk FactorsFemaleMalePredictive Learning ModelsDisease ProgressionBoosting Machine Learning AlgorithmsPredictive Value of TestsTime FactorsMiddle AgedReproducibility of ResultsPrediction AlgorithmsPrognosisAged, 80 and over

Stichwörter der Autor:innen

1-year readmissionacute exacerbation of chronic obstructive pulmonary diseasehypertensionmachine learningweb calculator

Autor:innen und Institutionen

  • Department of Pulmonary and Critical Care Medicine, The First Affiliated Hospital of Shihezi University, Shihezi, People's Republic of China.
  • Shihezi University School of Medicine, Shihezi, People's Republic of China.

ORCID-Profile: Dong Liu

Zitieren

APA

Zhang, X., He, M., Zhang, J., Zhao, L., & Liu, D. (2026). An Interpretable AdaBoost Model for 1-Year Readmission Risk Prediction in AECOPD Patients with Hypertension. International Journal of Chronic Obstructive Pulmonary Disease. https://doi.org/10.2147/copd.s557298

Vancouver

Zhang X, He M, Zhang J, Zhao L, Liu D. An Interpretable AdaBoost Model for 1-Year Readmission Risk Prediction in AECOPD Patients with Hypertension. International Journal of Chronic Obstructive Pulmonary Disease. 2026. doi:10.2147/copd.s557298

BibTeX
@article{Zhang2026,
  author = {Zhang, Xinxin and He, Maolang and Zhang, Jingyi and Zhao, Luna and Liu, Dong},
  title = {An Interpretable AdaBoost Model for 1-Year Readmission Risk Prediction in AECOPD Patients with Hypertension},
  journal = {International Journal of Chronic Obstructive Pulmonary Disease},
  year = {2026},
  doi = {10.2147/copd.s557298}
}
Kostenlos starten →